首页> 中文期刊> 《中国药房》 >增效磺胺嘧啶银混悬剂的制备与质量控制

增效磺胺嘧啶银混悬剂的制备与质量控制

         

摘要

OBJECTIVE: To prepare Synergist flamazine suspension and to establish the method for its quality control. METHODS: Synergist flamazine suspension was prepared with flamazine and trimethoprim. The contents of flamazine and trimethoprim were determined by HPLC and the stability of the preparation was studied. RESULTS: The linear ranges of flamazine and trimethoprim were 20-300 μg/ml and 8-120 μg/ml (both r=0.999 9). Average recoveries were 99.76% (RSD=0.38%) and 100.27% (RSD=0.41% ). Average contents of flamazine and trimethoprim in 3 batches of sample were 49.774 mg/ml and 20.045 mg/ml. The stability of suspension was good in dark place at room temperature within 6 months. CONCLUSION: Preparation technology of Synergist flamazine suspension is reasonable and stable in quality.%目的:制备增效磺胺嘧啶银混悬剂并建立其质量控制方法.方法:以磺胺嘧啶银配伍甲氧苄啶制备增效磺胺嘧啶银混悬剂,采用高效液相色谱法测定磺胺嘧啶银和甲氧苄啶的含量,并考察制剂稳定性.结果:磺胺嘧啶银和甲氧苄啶检测质量浓度分别在20~300、8~120 μg/ml范围内与峰面积积分值线性关系良好(r均为0.999 9),平均回收率分别为99.76%、100.27%,RSD分别为0.38%、0.41%;3批样品中磺胺嘧啶银和甲氧苄啶的平均含量分别为49.774、20.045 mg/ml;制剂在室温、避光条件下6个月内稳定性良好.结论:增效磺胺嘧啶银混悬剂制备工艺合理,质量稳定可控.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号